Prab: CSV import

2025-02-20T00:35:26Z

CSV import

← Older revision		Revision as of 00:35, 20 February 2025
Line 29:		Line 29:

	{{stub}}		{{stub}}
			== RTI-126 ==
			<gallery>
			File:2β-(3-methyl-5-isoxazolyl)nortropane structure.png\|RTI-126
			</gallery>

Prab: CSV import

2024-02-25T21:02:05Z

CSV import

New page

'''RTI-126''' is a [[psychoactive drug]] and [[research chemical]] that was first developed in the 1990s by the [[Research Triangle Institute]] (RTI). It is part of a series of compounds known as the [[RTI compounds]], which were created in an attempt to develop a substance that could be used as a [[cocaine]] substitute. RTI-126 is a [[dopamine reuptake inhibitor]], meaning it increases the levels of [[dopamine]] in the brain by blocking its reuptake into neurons.

==Chemistry==

RTI-126 is a [[tropane]] derivative, which is a class of compounds that includes many naturally occurring alkaloids. It is structurally similar to cocaine, but with a different [[substitution (chemistry)|substitution]] pattern on the tropane ring. The compound is also known as 3β-(4-chlorophenyl)-2β-[3-(4'-methylphenyl)isoxazol-5-yl]tropane or RTI-4229-126.

==Pharmacology==

As a dopamine reuptake inhibitor, RTI-126 increases the levels of dopamine in the brain. Dopamine is a neurotransmitter that plays a key role in reward, motivation, and motor control. By blocking the reuptake of dopamine, RTI-126 can produce effects similar to those of cocaine, including increased energy, euphoria, and increased alertness.

However, unlike cocaine, RTI-126 does not have a significant effect on the reuptake of [[norepinephrine]] or [[serotonin]], which may result in a different side effect profile. The exact effects of RTI-126 in humans are not well-studied, as the compound is primarily used as a research chemical.

==Legal Status==

RTI-126 is not currently controlled under the [[United Nations]] [[Convention on Psychotropic Substances]], but it may be considered illegal in some countries under analogue laws. In the [[United States]], RTI-126 is not specifically listed as a controlled substance, but it could potentially be considered a [[Federal Analogue Act|controlled substance analogue]].

==See Also==

* [[RTI-31]]
* [[RTI-55]]
* [[RTI-121]]
* [[RTI-352]]
* [[RTI-371]]

[[Category:Psychoactive drugs]]
[[Category:Research chemicals]]
[[Category:Dopamine reuptake inhibitors]]
[[Category:RTI compounds]]

{{stub}}

RTI-126 - Revision history

Prab: CSV import

Prab: CSV import